Accomplished HR Leader Will Oversee Growth of High-Performance, Diverse Workforce
BOSTON – March 2, 2020 – ConcertAI, a developer Real-World Evidence (RWE) and enterprise AI technologies for Precision Medicine, announced today that Lisa Archer has joined the company as Senior Vice President of People and Culture. Lisa has more than two decades of experience developing global teams and running world-class programs that bring out the best in people.
ConcertAI is one of the fastest growing healthcare technology companies and the leader for integrated RWE and AI solutions. Its mission is to transform healthcare by revolutionizing clinical and outcomes research, accelerate insights benefiting patients and bring an array of solutions supporting the entire patient treatment journey to both life science companies and healthcare providers.
Lisa’s expertise in building organizations with diverse sets of top clinical, data science, and engineering talent is exceptional and crucial to ConcertAI. “People and Culture are central to our mission and Lisa has the ideal set of skills to assure that ConcertAI can attract, develop, and retain the industry’s top talent,” said Jeff Elton, PhD and CEO of ConcertAI. “As we work with healthcare providers, medical societies, and life sciences companies, Lisa’s experience and success growing technology and healthcare companies is exactly what we need to meet our mission and improve clinical outcomes for cancer patients with the most innovative technology solutions.”
Previously, Lisa was the Senior Vice President of People and Culture at American Well. Prior to her role at American Well, she served as Vice President and Chief Human Resources Officer at Dynatrace, where she led her team to support the global, 1800-employee organization. Lisa’s professional experience also includes roles at Microsoft, EMC and Parametric Technology.
“I am honored to have the opportunity to influence an organizational culture that positions us to attract, develop, and retain a talented, culturally diverse workforce,” said Lisa. “I look forward to partnering with some of the strongest talent in the industry to further our mission to transform healthcare and improve clinical outcome for cancer patients.”